Welcome to the e-CCO Library!

P791: Influence of patients’ preference in randomised controlled trials
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

K. Wasmann*1, P. Wijsman2, S. van Dieren3, W. Bemelman4, C. Buskens4

Created: Friday, 22 February 2019, 9:41 AM
P791: Peripheral spondyloarthritis, peripheral arthritis, and IBD-related peripheral arthritis in patients with long-term IBD: Results from 20 years of follow-up in the IBSEN study
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Ossum1,2*, Ø. Palm3, M. Cvancarova4, B. Moum1,2, M. Høivik1, The IBSEN Study Group1,5

Created: Thursday, 21 February 2019, 9:14 AM
P791: Up to one third of rapid thiopurine-S-methyltransferase metabolizers manifest clinical and/or laboratory azathioprine side effects: A single centre experience
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Lababidi, N.E.(1)*;Pavel, F.(1);
Created: Friday, 14 July 2023, 11:12 AM
P792 Breastfeeding in our patients with inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Charro Calvillo1, M. Charro-Calvillo1, E. Peña-Gonzalez2, Y. Ber-Nieto3, M.T. Botella Esteban9, M.J. Alcalá Escriche4, P. Lacarta García9, E. Fernandez Bonilla5, A. Mir Subías6, M.T. Arroyo-Villarino9, E. Lafambra Cabrejas9, J. Nerin De la puerta7, R. Vicente Lidón9, S. García López9, P. Corsino Roche8

Created: Thursday, 30 January 2020, 10:12 AM
P792: Modulation of the fecal metagenome in patients with Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Rojas-Feria M.*1, Fernández Caballero-Rico J.A.2, Pastor Ramírez H.3, Castro-Fernandez M.1, Chueca Porcuna N.2, Grande Santamaría L.1, Romero-Gόmez M.3, García F.2, Del Campo J.A.1

Created: Wednesday, 20 February 2019, 10:36 AM
P792: Pharmacokinetics and clinical evaluation of vedolizumab based on real-life routine monitoring data in IBD patients
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Markovic, S.(1)*;Kralj, D.(1);Odanovic, O.(1);Homšek, A.(2);Kalaba, A.(1);Svorcan, P.(1);Vučićević, K.(2);
Created: Friday, 14 July 2023, 11:12 AM
P792: Phenotype and natural history of inflammatory bowel disease: results from the largest centre in Singapore
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

W. P. W. Chan*1,2, M. S. Lim1, A. X. H. Tan1, K. Chen1, A. T. M. Gan1, T. G. Lim1, W. C. Ong1, S. C. Kong3, H. H. Shim1

Created: Friday, 22 February 2019, 9:41 AM
P792: Prevalence of inflammatory bowel diseases in Israeli Jewish and Druze adolescents, a longitudinal comparative study
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Daher1*, L. Katz2,3, T. Khoury1, E. Lev4, A. Assa5, E. Israeli1

Created: Thursday, 21 February 2019, 9:14 AM
P793 Patients’ concerns are strongly associated with distress and quality of life among family caregivers of adult inflammatory bowel disease patients in remission
Year: 2020
Source:

ECCO'20 Vienna

Authors:

K. Argyriou1, P. Karantanos2, N. Vasilakis2, A. Kapsoritakis1, E. Lalla2, K. Varytimiadis2, G. Mpetsios2, E. Tsakiridou3, S. Potamianos1

Created: Thursday, 30 January 2020, 10:12 AM
P793: Infliximab and prevention of colectomy in acute severe ulcerative colitis: an individual patient data meta-analysis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Wang, Z.(1)*;Afif , W.(2);Hanžel, J.(3,4);Kobayashi , T.(5);Papamichail , K.(6);Roblin , X.(7);Peyrin-Biroulet , L.(8);Vermeire , S.(9);Dreesen, E.(1);
Created: Friday, 14 July 2023, 11:12 AM
P793: Microbial composition in IBD may influence clinical symptoms independent of endoscopic activity
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Boland K., Turpin W., Mohammadi A., Borowski K., Kabakchiev B., Smith M.I., Nguyen G., Steinhart A.H., Croitoru K., Silverberg M.

Created: Wednesday, 20 February 2019, 10:36 AM
P793: Prevalence and phenotype of inflammatory bowel disease across primary and secondary care: Implications for colorectal cancer surveillance
Year: 2018
Source: ECCO '18 Vienna
Authors:

N. Heerasing, P.J. Hendy, L. Moore, G.J. Walker, C. Bewshea, T. Ahmad, J. Goodhand, N.A. Kennedy*

Created: Thursday, 21 February 2019, 9:14 AM
P793: The cost burden of Crohn’s disease and ulcerative colitis dependent on biologic treatment status – a register-based Danish population study from 2003 to 2015
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Alulis1, K. Vadstrup*1, A. Borsi2, N. Gustafsson3, T. R. Jørgensen4, P. Munkholm5, N. Qvist6

Created: Friday, 22 February 2019, 9:41 AM
P794 Nutritional assessment in inflammatory bowel disease (IBD): development of the Groningen IBD Nutritional Questionnaires (GINQ)
Year: 2020
Source:

ECCO'20 Vienna

Authors:

V. Peters1, B. Alizadeh2, J. de Vries3, G. Dijkstra1, M. Campmans-Kuijpers1

Created: Thursday, 30 January 2020, 10:12 AM
P794: Alterations of intestinal microbiota in ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Danilova N.1, Abdulkhakov S.1,2, Grigoryeva T.*2, Dubinkina V.3, Odintsova V.4, Tyakht A.3,4, Pavlenko A.4, Odintsova A.2, Abdulkhakov R.1, Govorun V.4

Created: Wednesday, 20 February 2019, 10:36 AM
P794: Effectiveness of administering zinc acetate hydrate to patients with inflammatory bowel disease and zinc deficiency: a retrospective observational two-center study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Sakurai, K.(1)*;Katsurada, T.(1);Aoyama, K.(1);Fukushima, S.(1);Onishi, R.(1);Yagisawa, K.(2);Nishimura, H.(2);Ito, T.(2);Furukawa, S.(2);Maemoto, A.(2);Sakamoto, N.(1);
Created: Friday, 14 July 2023, 11:12 AM
P794: Fatigue in inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

P. Schreiner*1, J-B. Rossel2, L. Biedermann1, M. Scharl1, J. Zeitz3, P. Frei4, T. Greuter1, S. Vavricka5, V. Pittet6, A. Siebenhüner7, P. Juillerat8, R. von Känel9, G. Rogler1, B. Misselwitz1,8

Created: Friday, 22 February 2019, 9:41 AM
P794: Vaccination and impact of vaccination for influenza among inflammatory bowel disease (IBD) patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

C. Trivedi1, H. Kavani1, N. Khan1,2*

Created: Thursday, 21 February 2019, 9:14 AM
P795 Risk of incident paradoxical immune-mediated inflammatory diseases in patients with inflammatory bowel diseases treated with anti-TNF therapies: a nationwide Danish cohort study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

D. WARD1, S. Gørtz1, N. Nyboe Andersen2, J. Kirchgesner3,4, T. Jess1

Created: Thursday, 30 January 2020, 10:12 AM
P795: A specialised inflammatory bowel disease service provides equality of access to healthcare, irrespective of deprivation indices
Year: 2018
Source: ECCO '18 Vienna
Authors:

D. Sawbridge1, D. Storey1, B. Gregg1, C. Probert1,2, M. Burkitt1,2*

Created: Thursday, 21 February 2019, 9:14 AM